利用新技术能够从少量血样中快速收集血浆
By LabMedica International staff writers Posted on 19 Jun 2014 |

图片:Noviplex Card——快速收集和分析血浆的下一代样本采集技术(图片蒙岛津科学仪器公司惠赐)。
一种“卡片实验室”采集技术现在能用一份指血样本快速生成LC-MS/MS分析等应用所需的高质量血浆。
日本京都岛津公司的子公司岛津科学仪器公司(SSI; Columbia, MD, USA)推出了下一代样本收集工具——Noviplex卡片,可加快血浆的采集和分析。这种卡片可在几分钟内用未经测量的少量全血采集一定容积的血浆样本。它非常适用于LC-MS/MS分析。Noviplex还具有独立于血细胞比容的超常的可重复性,可去除99%的红细胞,并为基于MS的分析快速制备样本,同时维持测定的可重复性和选择性。
Noviplex卡片无需静脉切开术、针筒和玻璃采集管,从而简化了血液收集。用于生成血浆的样本容积范围是20–75微升的全血。该技术为样本制备和分析物萃取提供了一步式的固相方法。它消除了冷藏、离心、溶剂萃取和蒸发等过程,加速了处理。
岛津与Novilytic实验室(Novilytic; North Webster, IN, USA/)合作推出了Noviplex卡片。普渡大学化学教授、Novilytic公司创始人之一Fred Regnier博士说:“Novilytic实验室在样本收集和制备方面的新进展大大加速了疾病标记物的分析并改变了临床化学、健康监护和医疗的规范。”SSI生命科学事业部经理Scott Kuzdzal博士说:“Noviplex技术实现了无需实验室的样本制备,方便的‘卡片实验室’格式能快速生成血浆,供LC-MS/MS分析所用。这将极大简化诊所、化验室和医院的收集和处理。”
Related Links:
岛津科学仪器公司
Noviplex卡片
Novilytic实验室
日本京都岛津公司的子公司岛津科学仪器公司(SSI; Columbia, MD, USA)推出了下一代样本收集工具——Noviplex卡片,可加快血浆的采集和分析。这种卡片可在几分钟内用未经测量的少量全血采集一定容积的血浆样本。它非常适用于LC-MS/MS分析。Noviplex还具有独立于血细胞比容的超常的可重复性,可去除99%的红细胞,并为基于MS的分析快速制备样本,同时维持测定的可重复性和选择性。
Noviplex卡片无需静脉切开术、针筒和玻璃采集管,从而简化了血液收集。用于生成血浆的样本容积范围是20–75微升的全血。该技术为样本制备和分析物萃取提供了一步式的固相方法。它消除了冷藏、离心、溶剂萃取和蒸发等过程,加速了处理。
岛津与Novilytic实验室(Novilytic; North Webster, IN, USA/)合作推出了Noviplex卡片。普渡大学化学教授、Novilytic公司创始人之一Fred Regnier博士说:“Novilytic实验室在样本收集和制备方面的新进展大大加速了疾病标记物的分析并改变了临床化学、健康监护和医疗的规范。”SSI生命科学事业部经理Scott Kuzdzal博士说:“Noviplex技术实现了无需实验室的样本制备,方便的‘卡片实验室’格式能快速生成血浆,供LC-MS/MS分析所用。这将极大简化诊所、化验室和医院的收集和处理。”
Related Links:
岛津科学仪器公司
Noviplex卡片
Novilytic实验室
Latest 实验室技术 News
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Simple Blood Test Better Predicts Heart Disease Risk
Cardiovascular diseases (CVDs) are the primary cause of death worldwide. A large proportion of these cases could be prevented by addressing lifestyle and environmental factors such as smoking, poor diet,... Read more
New Blood Test Detects 12 Common Cancers Before Symptoms Appear
Bowel cancer is the fourth most common cancer in the UK, with over 42,000 new diagnoses each year. Detecting bowel cancer in its early stages can be challenging, and as the disease progresses, survival... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more